Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Consider running retatrutide as monotherapy at its full dose range first, as the triple agonist alone produces excellent results
Supports post-workout recovery (not approved by WADA)
Since peptides are, by definition, short chains of amino acids, they are vulnerable to this digestive onslaught
While no major safety flags have emerged from either the scientific literature or widespread anecdotal use, the absence of large-scale human data means users should proceed carefullyespecially if considering high doses or long-term use
Standard titration schedule from trials 12-week escalation protocol: Weeks 1-4: 0.6mg weekly Initiation dose Body adapts to amylin effects Minimal side effects at this level Weight loss begins (modest) Weeks 5-8: 1.2mg weekly First dose increase (doubling) Gastric slowing becomes more noticeable Appetite suppression strengthens Accelerated weight loss Weeks 9-12: 1.8mg weekly Second increase Strong satiety effects More pronounced GI effects possible Approaching maximum efficacy Week 13+: 2.4mg weekly (maintenance) Target therapeutic dose Maximum weight loss velocity Maintained indefinitely Nausea typically resolved by this point (adapted) Why this schedule works: Gradual exposure reduces side effects 4-week intervals allow full adaptation Doubling steps (0.61.22.4) are tolerable Proven in hundreds of patients Balances speed with tolerability Use our peptide calculator and peptide dosing guide at SeekPeptides for precise calculations
